Patent ID: 7026343

Claim:
A method of inhibiting growth or proliferation of a cancer cell, comprising contacting the cell with an amount of a compound that interferes with c-Myc and Max association effective to inhibit growth or proliferation of the cell, wherein the compound is selected from the group consisting of: (a) Bicyclo[2.2.1]hept-2-yl-[2-(4-nitro-phenyl)-ethyl]-amine; (b) 4-Methyl-2- [N′-(6-methyl-2-phenyl-chroman-4-ylidene)-hydrazino]-thiazole-5-carboxylic acid (3-nitro-phenyl)-amide; (c) 5-(4-Ethyl-benzylidene)-2-thioxo-thiazolidin-4-one; (d) 3-[3-(3,6-Dichloro-carbazol-9-yl)-2-hydroxy-propyl]-thiazolidine-2,4-dione; (e) Biphenyl-2-yl-(7-nitro-benzo[1,2,5]oxadiazol-4-yl)-amine; (f) 1-(3-Chloro-phenyl)-3-diethylamino-pyrrolidine-2,5-dione; and (g) 1-[2,5-dioxo-1-(4-propoxy-phenyl)-pyrrolidin-3-yl]-piperidine-4-carboxylic acid, or a pharmaceutically acceptable salt thereof.